Comparison of the Effectiveness of Ocrelizumab Vs Interferons, Fingolimod and Natalizumab on Relapses in Relapsing-Remitting Multiple Sclerosis

AuthID
P-00V-R9Z
48
Author(s)
Roos, I
·
Sharmin, S
·
Havrdova, EK
·
Patti, F
·
Terzi, M
·
Lechner Scott, J
·
[+28]·
Ramo Tello, C
·
McCombe, P
·
Willekens, B
·
Spitaleri, D
·
Ampapa, R
·
Al Asmi, A
·
Slee, M
·
Besora, S
·
Malpas, C
·
Kalincik, T
1
Group Author(s)
MSBase Study Grp
Document Type
Abstract
Year published
2021
Published
in MULTIPLE SCLEROSIS JOURNAL, ISSN: 1352-4585
Volume: 27, Issue: 2_SUPPL, Pages: 778-780 (3)
Indexing
Publication Identifiers
Wos: WOS:000706771302336
Source Identifiers
ISSN: 1352-4585
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Roos, I;   2 Sharmin, S;   3 Ozakbas, S;
4 Horakova, D;   5 Havrdova, EK;   6 Boz, C;
7 Alroughani, R;   8 Patti, F;   9 Terzi, M;
10 Lechner Scott, J;   11 Izquierdo, G;   12 Eichau, S;
13 Grammond, P;   14 Buzzard, K;   15 Skibina, O;
16 Prat, A;   17 Girard, M;   18 Duquette, P;
19 Soysal, A;   20 Grand'Maison, F;   21 Kuhle, J;
22 van der Walt, A;   23 Butzkueven, H;   24 Turkoglu, R;
25 Butler, E;   26 Laureys, G;   27 van Hijfte, L;
28 Shaygannejad, V;   29 Yamout, B;   30 Khoury, S;
31 Prevost, J;   32 Sidhom, Y;   33 Gouider, R;
34 Cartechini, E;   35 Sanchez Menoyo, JL;   36 Sa, MJ;
37 Macdonell, R;   38 van Pesch, V;   39 Ramo Tello, C;
40 McCombe, P;   41 Willekens, B;   42 Spitaleri, D;
43 Ampapa, R;   44 Al Asmi, A;   45 Slee, M;
46 Besora, S;   47 Malpas, C;   48 Kalincik, T;